A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema
NCT00308542 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2012-02-13
Summary
This study will evaluate the safety and efficacy of intravitreal implant of dexamethasone for the treatment of diabetic edema.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Sanwa Kagaku Kenkyusho Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Clinical Study Group, Clinical Development Dept. · Sanwa Kagaku Kenkyusho Co., Ltd.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Japan
Study Locations
More Related Trials
-
A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema
NCT00168337 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Intravitreal Triamcinolone to Treat Diffuse Diabetic Macular Edema
NCT00309192 ·Status: COMPLETED ·Phase: PHASE3
-
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:
NCT05847088 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
NCT00168298 ·Status: COMPLETED ·Phase: PHASE3
-
Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
NCT03559491 ·Status: COMPLETED
-
A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion
NCT00168324 ·Status: COMPLETED ·Phase: PHASE3
-
A Real-world Study to Assess Safety of OZURDEX® (Dexamethasone Intravitreal Implant) in Adult Participants With Diabetic Macular Edema in China
NCT06548568 ·Status: ACTIVE_NOT_RECRUITING
-
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
NCT05978622 ·Status: ACTIVE_NOT_RECRUITING
-
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema
NCT00799227 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
NCT05736081 ·Status: COMPLETED ·Phase: PHASE4
-
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
NCT02121197 ·Status: COMPLETED
-
Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.
NCT06846073 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
NCT04005430 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema
NCT04089605 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
NCT05712720 ·Status: COMPLETED ·Phase: PHASE2
-
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.
NCT04601675 ·Status: UNKNOWN ·Phase: NA
-
Effect of Dexamethasone Implant on Optic Disc
NCT03927118 ·Status: COMPLETED
-
Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema
NCT03385382 ·Status: COMPLETED
-
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
NCT06237777 ·Status: RECRUITING ·Phase: PHASE1
-
Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema
NCT00886808 ·Status: COMPLETED ·Phase: PHASE1
-
Study on Exosome Changes in Patients With Proliferative Diabetic Retinopathy
NCT06198543 ·Status: NOT_YET_RECRUITING
-
Shanghai Beixinjing Diabetic Eyes Study
NCT03571217 ·Status: UNKNOWN
-
Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
NCT03003416 ·Status: COMPLETED
-
Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)
NCT04116398 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
NCT04151407 ·Status: UNKNOWN ·Phase: PHASE1